Case Report: Immunotherapy-induced myocarditis requiring pacemaker insertion in an older adult. what happens if we rechallenge?

Immune checkpoint inhibitors (ICIs) have revolutionized the practice of oncology, becoming a cornerstone treatment for many cancers. Nivolumab, an antibody-targeting programmed cell death protein-1 (PD-1), and ipilimumab, an antibody-targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), ar...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Wassim Assaad, Nour El Meski, Omar Fakhreddine, Tarek El Halabi, Marwan Refaat, Firas Kreidieh
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2026-02-01
Saila:	Frontiers in Oncology
Gaiak:	case report immune-checkpoint inhibitors immunotherapy myocarditis rechallenge renal cell carcinoma
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1565918/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!